Use of Antipsychotics By Teens, Young Adults Rises
Males were more likely to be given antipsychotics than females, and among young adults given the drugs, depression was most common diagnosis.
HealthDay News — From 2006 to 2010, there was an increase in antipsychotic medication use among adolescents and young adults, according to a study published online in JAMA Psychiatry.
Mark Olfson, MD, MPH, from Columbia University in New York City, and colleagues conducted a retrospective descriptive analysis of antipsychotic prescriptions among patients aged 1 to 24 years using data from 2006, 2008, 2010, and a subset from 2009 with service claims data.
The researchers found that in 2006 and 2010 the percentages of young people using antipsychotics were 0.14 and 0.11%, respectively, for younger children (1 to 6 years); 0.85 and 0.80% for older children (7 to 12 years); 1.10 and 1.19% for adolescents (13 to 18 years); and 0.69 and 0.84% for young adults (19 to 24 years).
Males were more likely to use antipsychotics than females in 2010, particularly during childhood and adolescence. Among those treated with antipsychotics in 2010, younger children were less likely to receive a prescription from a psychiatrist than other age groups (57.9 versus 70.4 to 77.9%).
Among those with claims for mental disorders treated with antipsychotics, attention-deficit/hyperactivity disorder was the most common diagnosis in younger and older children and adolescents, and depression was the most common diagnosis in young adults.
"Peak antipsychotic use in adolescence, especially among boys, and clinical diagnosis patterns are consistent with management of developmentally limited impulsive and aggressive behaviors rather than psychotic symptoms," the authors write.
Olfson M, et al. Treatment of Young People With Antipsychotic Medications in the United States. JAMA Psychiatry. 2015; doi:10.1001/jamapsychiatry.2015.0500.
Correll CU and Blader JC. Editorial. Antipsychotic Use in Youth Without Psychosis: A Double-edged Sword. JAMA Psychiatry. 2015; doi:10.1001/jamapsychiatry.2015.0632.